Percutaneous transluminal angioplasty (PTA) is now more frequently used to improve tissue perfusion in ischemic diabetic feet. However, there are concerns about its feasibility and effectiveness in severely ischaemic feet. This study aimed to compare the perfusion values after PTA according to the ischaemic degree of diabetic feet. This study included 133 ischaemic diabetic feet. The foot transcutaneous oxygen pressure (TcPO 2 ) and toe pressure were measured before the procedure and every second postoperative week for 6 weeks. The patients were divided into three groups according to ischaemic severity on the basis of TcPO 2 and toe pressures. In the "severely ischaemic" group, the TcPO 2 increased from 7.5 AE 4.9 to 40.3 AE 11.3 mm Hg (5.4-fold) 6 weeks after the PTA (P < 0.001). The toe pressure increased from 8.5 AE 8.8 to 42.2 AE 19.3 mm Hg (5.0-fold, P < 0.001). In the "mild" group, the TcPO 2 increased from 35.4 AE 2.5 to 41.8 AE 12.4 mm Hg (1.2-fold, P = 0.003), and the toe pressure increased from 45.7 AE 12.3 to 54.3 AE 31.3 mm Hg (1.2-fold, P > 0.05). Results of the "intermediate" group were in between. The most severely ischaemic group had the most dramatic increase of tissue perfusion after PTA. As such, PTA can be an effective method for increasing tissue perfusion even in the severely ischaemic diabetic feet.
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| INTRODUCTION
Adequate tissue perfusion is an essential factor in diabetic foot management, 1 and bypass graft surgery and percutaneous transluminal angioplasty (PTA) are generally recommended to improve tissue perfusion of ischaemic diabetic feet. Bypass graft surgery has been the mainstay of revascularisation therapy for ischaemic feet. There are many reports showing the value of bypass surgery; however, this surgery is an invasive procedure associated with perioperative mortality and morbidity. 2 In particular, patients with severe ischaemia are at a higher risk of subsequent cardiovascular events, including myocardial infarction, stroke, and death. 3, 4 In addition, bypass surgery requires at least one patent artery and a good vein. Alternatively, PTA has been used with an increased frequency in recent years for the treatment of diabetic feet. 5, 6 It is a less invasive procedure than bypass graft surgery, and several studies have demonstrated good results for PTA in terms of patency and limb salvage. [7] [8] [9] [10] [11] In PTA, there is no need for general anaesthesia, and there are fewer associated wound problems. PTA allows for the preservation of the saphenous vein and thus can be performed repeatedly. Furthermore, on the basis of improved technical options for PTA, a significantly better outcome is now expected for the procedure. It is now well accepted that PTA is the modality Table 1 . For the evaluation of tissue perfusion, the foot TcPO 2 and toe pressure were measured before PTA and every 2 weeks for 6 weeks after PTA at the same location. Changes in the TcPO 2 and toe pressures were compared between the subgroups.
The study protocol was approved by the institutional review board of Korea University Guro Hospital (#KUGH 15092-001). This study was performed in full accordance with the Declaration of Helsinki principles.
| Measurements of the TcPO 2 and toe pressure
The TcPO 2 was measured using a PF5040 TcPO 2 unit (PeriFlux System 5000; Perimed AB, Stockholm, Sweden) paired with the PeriSoft programme (PeriSoft for Windows 2.50; Perimed AB). The TcPO 2 probe was fixed onto the dorsum of the foot adjacent to an ulcer. The TcPO 2 was always measured on the dorsum of the foot in an area directly opposite of the lesion, even if the ulcer was present on the plantar aspect. The TcPO 2 was measured at the tarsometatarsal level in cases where an ulcer was not present and with the patients in a resting supine position. The TcPO 2 was recorded at 43 C after a 20-minute equilibration period.
Toe pressure was assessed using a miniature cuff placed around the base of the great toe. In situations where toe pressure measurement on the great toe was difficult or impossible, the other toes were used alternatively. A laser Doppler perfusion monitor was used to show when the blood flow would re-start during cuff deflation from the suprasystolic values. The measuring probe was positioned at the tip of the toe. The PeriFlux 5000 toe pressure system (Perimed AB) was used.
| PTA procedure
PTA was performed under local anaesthesia by an interventional cardiologist of the Diabetic Wound Center (the fifth author of this study) using digital fluoroscopy guidance. Standard techniques were used for PTA. For below-the-knee lesions, a 5-Fr Heartrail guiding catheter (Terumo, Tokyo, Japan) was used, and a 0.014-in guidewire was used to traverse the lesions. If the intraluminal wiring failed, subintimal angioplasty or a retrograde approach was used. After the guidewire crossing, prolonged balloon inflations (120 seconds) with balloon sizes ranging from 1.5 to 3.5 mm were used. If the balloon angioplasty results were suboptimal, then provisional stenting was performed using selfexpanding nitinol stents (Xpert; Abbott Vascular, Abbott Park, Illinois; Medtronic-Invatec, Minneapolis, Minnesota).
For the superficial femoral artery (SFA) and the iliac artery, true lumen angioplasty was attempted for chronic total occlusion (CTO) using dedicated 0.018-in CTO wires. If unsuccessful, then subintimal angioplasty using a 0.035-in soft Terumo wire (1.5 J curve) with 5-Fr angiocatheter support was performed for longer CTO lesions, with provisional
Key Messages
• percutaneous transluminal angioplasty (PTA) is now more frequently used to improve tissue perfusion in ischaemic diabetic feet; however, there are concerns about its feasibility and effectiveness in severely ischaemic feet, and no clinical study has compared the perfusion values after PTA according to the degree of ischaemia
• this study aimed to estimate the efficacy of PTA in severely ischaemic diabetic feet
• PTA can be an effective method to improve tissue oxygenation and toe pressure even in severely ischaemic diabetic feet spot stenting using self-expanding nitinol stents; wiring of the true lumen was performed for shorter CTO lesions. If the subintimal wiring failed to re-enter the distal true lumen for femoropopliteal CTO lesions, then re-entry by CTO wires or a re-entry device (Outback Catheter; Cordis, Miami Lakes, Florida) was conducted. The retrograde approach from the distal SFA, popliteal, or infrapopliteal arteries was performed in selected cases.
| Statistical analysis
All data were expressed as means AE SDs. The Friedman test was performed to determine the TcPO 2 /toe pressure differences between the time points. The Wilcoxon signed rank test was used to analyse the statistical significance of the TcPO 2 /toe pressures between the pair of time points. The repeated measures ANOVA test was used to analyse the statistical significance of the different trends among the subgroups. The Kruskal-Wallis test was used to determine the TcPO 2 /toe pressure differences among the subgroups. The Mann-Whitney U test was used to analyse the differences in the TcPO 2 /toe pressures between two subgroups at each time point. The amounts of increased values were compared using the Mann-Whitney U test. A P-value <0.05 was considered statistically significant.
| RESULTS
Before PTA, the average TcPO 2 was 20.0 AE 12.2 mm Hg. After PTA, the TcPO 2 increased progressively. The TcPO 2 2, 4, and 6 weeks after PTA was 36.7 AE 13.3, 39.0 AE 11.9, and 39.1 AE 11.8 mm Hg, respectively (P < 0.01, Friedman test). Every measured TcPO 2 after PTA significantly improved when compared with the initial value (P < 0.01, Wilcoxon signed rank test). The highest TcPO 2 was observed on the 6th week after PTA. However, there was no statistically significant difference between the TcPO 2 on the 4th and 6th weeks after PTA ( Figure 1 and Table 2 ).
The amounts of increased TcPO 2 were significantly different among the three subgroups (P < 0.05, Kruskal-Wallis test). The increase was most notable and dramatic in the "severe" group ( Figure 2) . The difference in the measured TcPO 2 before and after PTA was significantly greater in the "severe" group than in the other two groups (Table 3) . Especially in the 4th and 6th weeks after PTA, the average TcPO 2 of the "severe" group reached levels similar to those of the "intermediate" and "mild" groups ( Table 4) . The average toe pressures also increased immediately after revascularisation. Before PTA, the average toe pressure was 31.7 AE 21.8 mm Hg. The toe pressures 2, 4, and 6 weeks after PTA were 50.4 AE 27.4, 54.6 AE 26.2, and 51.2 AE 24.9 mm Hg, respectively (P < 0.01, Friedman test). Every measured toe pressure after PTA significantly improved when compared with the initial value (P < 0.01, Wilcoxon signed rank test). The highest measured toe pressure was observed in the 4th week after PTA. There was a significant difference between the toe pressures in the 4th and 6th weeks ( Figure 3 and Table 2 ).
Similar to the TcPO 2 results, the "severe" group showed the most notable increase among the groups. The difference in the measured toe pressures before and after PTA was significantly greater in the "severe" group than in the other two groups ( Table 3) . The difference in the trend among the three subgroups was highly significant (P < 0.001, repeated measures ANOVA; Figure 4 ). In particular, the average toe pressure of the "severe" group in the 4th week after PTA reached similar levels to those of the "intermediate" and "mild" groups (Table 4) .
| DISCUSSION
The results of this study demonstrated that PTA can lead to favourable outcomes in terms of tissue oxygenation and toe pressure even in severely ischaemic limbs (TcPO 2 of <20 mm Hg and toe pressure of <30 mm Hg). The most severely ischaemic group showed a much more dramatic increase in tissue oxygenation and toe pressure after PTA than did the "intermediate" and "mild" groups. This result might reflect a paradigm shift towards the PTA in revascularisation for severely ischaemic feet. In the past, the gold standard for the treatment of severely ischaemic limbs has been open bypass surgery 2, 12, 13 as the therapeutic results of PTA appeared to be less effective. In this study, we demonstrated that PTA can be performed without any particular contraindications even in patients with severe ischaemia with a high surgical risk. PTA may be a first-line treatment option even for severely ischaemic diabetic feet. Faglia et al 8 performed a study comparing the feasibility of peripheral revascularisation via PTA to that of bypass graft surgery in diabetic patients with critical limb Abbreviations: PTA, percutaneous transluminal angioplasty; TcPO 2 , transcutaneous oxygen pressure. *P < 0.05; **P < 0.01.
FIGURE 2
Changes in the mean TcPO 2 in the three subgroups, grouped according to the severity of their ischaemia. The amounts of the increased TcPO 2 were significantly different among the three subgroups. The increase was most notable in the "severe" group. In the 4th and 6th weeks after PTA, the average TcPO 2 of the "severe" group reached similar levels to those of the "intermediate" and "mild" groups. PTA, percutaneous transluminal angioplasty; TcPO 2 , transcutaneous oxygen pressure ischaemia. For their study, bypass grafting was performed in patients at a low surgical risk who presented a long femoral occlusion with at least one infrapopliteal artery patent down to the foot. In patients with significant comorbidities, PTA was attempted. The outcomes were evaluated by observing the patient symptoms, including limb pain, and by assessing the rates of amputation, recurrence, or mortality. In the study, PTA showed a comparable outcome to bypass graft surgery. However, they determined the effect of PTA by observing symptoms and signs. As such, the clinical outcomes may be more important than only changes in tissue perfusion for determining the ultimate clinical effect of PTA. Nevertheless, it should be emphasised that the outcomes of symptoms and signs could be influenced by many factors other than tissue perfusion. Therefore, our study focused on improvements in the TcPO 2 and toe pressures, which may reflect the benefits of PTA more objectively.
In our study, the TcPO 2 continued to increase until the 6th week after PTA. However, there was no statistical difference between the 4th and 6th weeks after the procedure. Therefore, a statistical peak value for the TcPO 2 was detected in the 4th week. Specifically, only 8 patients (6%) had decreased TcPO 2 , whereas 125 patients (94%) had improved TcPO 2 , in the 6th week after PTA compared with their pre-PTA values. In addition, the TcPO 2 value of 96 patients (72%) continued to increase until the 6th week after PTA, whereas that of 37 patients (28%) decreased from the 4th week after PTA. There are several hypotheses for the delayed increase. One of them concerns ischaemiareperfusion injury and the resultant inflammation and Abbreviation: TcPO 2 , transcutaneous oxygen pressure. *P < 0.05; **P < 0.01.
FIGURE 3
Sequential values of the mean toe pressure. All treated feet (133 ft) were assessed at each time point. The pins at each time point represent one SD FIGURE 4 Changes in the mean toe pressure in the three subgroups, grouped according to the severity of their ischaemia. Similar to the TcPO 2 results, the "severe" group showed a notable increase compared with the milder groups. In the 4th week after PTA, the average toe pressure of the "severe" group reached similar levels to those of the "intermediate" and "mild" groups. However, in contrast to the TcPO 2 increasing until the 6th week after PTA, the toe pressures decreased after reaching their peak level on the 4th week. PTA, percutaneous transluminal angioplasty; TcPO 2 , transcutaneous oxygen pressure oxidative damage. The activated endothelial cells produce more reactive oxygen species but less nitric oxide following reperfusion, and the imbalance results in a subsequent inflammatory response. The production of metabolic factors, such as free oxygen radicals, lactic acid, and vasoactive peptides, can cause tissue injury. 14 Another reason for the delay in reaching the peak level of tissue oxygenation may be transient oedema of the lower limb after PTA. [15] [16] [17] In our previous study on 29 limbs of 23 patients, the TcPO 2 reached its peak level in the 4th week after PTA, 18 and the TcPO 2 was lower than the peak level in the 5th and 6th weeks after PTA. However, the results of the current study indicated that the TcPO 2 continued to increase throughout the 6th week. The improvement of the outcome may be caused by advancements in instrumentation and techniques for PTA. The accumulated experiences of our staff and device innovation may enable a higher success rate and more durable results. In this study, even the invisible far distal vascular beds could be saved by angioplasty; this was carried out either by intraluminal wiring or subintimal wiring and by a unidirectional or bidirectional approach (including a retrograde approach). Improvements in "medical therapy after PTA" could have also improved the results. All patients were prescribed triple antiplatelet therapy as follows: salicylic acid (100 mg/day), clopidogrel (75 mg/day), and cilostazol (200 mg/day) indefinitely. During the periprocedural period, enoxaparin (120 mg/day), an anticoagulant, was subcutaneously injected. In addition, alprostadil (10 μg/day), sarpogrelate (300 mg/day), limaprost alfadex (ie, prostaglandin E1; 30 μg/day), beraprost sodium (ie, prostaglandin I2; 0.06 mg/day), and Ginkgo biloba extract (160 mg/day) were appropriately added based on the patient's clinical condition. Strong statins such as rosuvastatin (10 mg/day) were also added for optimal medical therapy.
In contrast to the result that the TcPO 2 increased until the 6th week after PTA, the toe pressures decreased after reaching their peak level at 4th week post-PTA. These inconsistent results may be because of the formation of collateral microcirculations. The decrease in the toe pressure in the 6th week after PTA may directly reflect re-obstruction or restenosis of macrocirculation of a given toe. 19 By contrast, TcPO 2 measurement is based on measuring the partial pressure of oxygen by driving excess oxygen molecules from the capillary lumen. Even if the digital artery of the toe is restenosed, the TcPO 2 on the dorsal skin may be maintained as collateral microvessels were created. 20 Several techniques can be used to detect ischaemia and impaired microcirculation of the lower limb, including ankle-brachial index (ABI) assessment, Doppler, and angiography imaging. However, these techniques are more limited when examining actual tissue perfusion.
19,21 TcPO 2 measurement is acknowledged as the most reliable, representative, and accurate method for evaluating actual tissue oxygenation in patients with diabetic feet. 22 Moreover, the TcPO 2 provides a sensitive means to assess the potential for wound healing. TcPO 2 measurement is a non-invasive diagnostic tool applied at the epidermal surface to determine the partial pressure of oxygen. It is also useful for determining the optimal amputation level, monitoring clinical progression, and evaluating the efficacy of revascularisation therapy. 23 The increase in the TcPO 2 following PTA has a higher specificity and sensitivity than ABI. 20, 24 In this study, the TcPO 2 standards for grouping the severity of ischaemia were selected on the basis of the minimal TcPO 2 thought to be required for adequate wound healing; conversely, the opinions of researchers and clinicians vary, with almost all estimates falling between values of 20 and 40 mm Hg. 22, [25] [26] [27] [28] Toe pressure measurement is also the recommended method for assessing the severity of ischaemia. Toe pressures are of a particular importance in patients experiencing medial sclerosis, such as those with diabetes, as this condition often leads to falsely elevated ankle pressures and a subsequent under-diagnosis of the disease. [29] [30] [31] The present study has some limitations. First, the followup period was not long enough to determine the long-term durability of PTA performed on ischaemic diabetic feet. Future studies might be useful for assessing the appropriate time point for the repeated revascularisation therapy. Second, the correlation between the changes in tissue oxygenation/toe pressure and their clinical outcome, including wound status or symptom changes, was not clearly identified as we focused on the trend of tissue perfusion in this study.
Although further research is required, we demonstrated that PTA significantly increases tissue oxygenation and toe pressure even in severely ischaemic diabetic feet. This study may be the first to show changes in the TcPO 2 and toe pressure according to the degree of ischaemia. Furthermore, our study demonstrated the time point at which the TcPO 2 and toe pressure reach their highest levels after PTA in a large number of patients with diabetes who were treated using an identical management protocol at a single centre.
| CONCLUSIONS
In this study, the most severely ischaemic group showed the most marked increase in tissue oxygenation and toe pressure after PTA. Furthermore, in the 4th week after PTA, the average TcPO 2 and toe pressure of the "severe" group reached a similar level to those of the "intermediate" and "mild" groups. In conclusion, PTA can be an effective method to improve tissue oxygenation and toe pressure even in severely ischemic diabetic feet.
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